GPT and metabolic dysfunction-associated steatotic liver disease: In the HOMA − IR > 1 group, the subjects with nonobese NAFLD also had higher BMI (23.5 ± 1.0 vs. 22.0 ± 1.6 kg/m2, P < 0.001) (Figure 1(a)), higher ALT (26.2 ± 9.5 vs. 18.6 ± 7.6 U/L, P = 0.001) (Figure 1(b)), higher AST (22.1 ± 5.4 vs. 18.8 ± 4.6 U/L, P = 0.042) (Figure 1(c)), higher TG (1.7 ± 1.2 vs. 1.1 ± 0.6 mmol/L, P < 0.001) (Figure 1(d)), and higher HbA1c (5.7 ± 0.2 vs. 5.4 ± 0.3%, P = 0.029) (Figure 1(e)) values relative to patients without NAFLD.